H. Lundbeck AS (FRA:LDBB) Days Payable : 388.86 (As of Mar. 2024)

View and export this data going back to 2022. Start your Free Trial

What is H. Lundbeck AS Days Payable?

H. Lundbeck AS's average Accounts Payable for the three months ended in Mar. 2024 was €577 Mil. H. Lundbeck AS's Cost of Goods Sold for the three months ended in Mar. 2024 was €135 Mil. Hence, H. Lundbeck AS's Days Payable for the three months ended in Mar. 2024 was 388.86.

The historical rank and industry rank for H. Lundbeck AS's Days Payable or its related term are showing as below:

FRA:LDBB' s Days Payable Range Over the Past 10 Years
Min: 313.89 Med: 367.39 Max: 396.98
Current: 336.1

During the past 13 years, H. Lundbeck AS's highest Days Payable was 396.98. The lowest was 313.89. And the median was 367.39.

FRA:LDBB's Days Payable is ranked better than
90.13% of 973 companies
in the Drug Manufacturers industry
Industry Median: 89.33 vs FRA:LDBB: 336.10

H. Lundbeck AS's Days Payable increased from Mar. 2023 (352.39) to Mar. 2024 (388.86). It may suggest that H. Lundbeck AS delayed paying its suppliers.

H. Lundbeck AS Days Payable Historical Data

The historical data trend for H. Lundbeck AS's Days Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

H. Lundbeck AS Days Payable Chart

H. Lundbeck AS Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Days Payable

Get a 7-Day Free Trial

380.97

335.43

382.82

377.23

352.75

H. Lundbeck AS Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Days Payable	Get a 7-Day Free Trial															352.39	314.32	337.57	320.01	388.86

Competitive Comparison of H. Lundbeck AS's Days Payable

For the Drug Manufacturers - Specialty & Generic subindustry, H. Lundbeck AS's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

H. Lundbeck AS's Days Payable Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, H. Lundbeck AS's Days Payable distribution charts can be found below:

* The bar in red indicates where H. Lundbeck AS's Days Payable falls into.

H. Lundbeck AS Days Payable Calculation

Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.

H. Lundbeck AS's Days Payable for the fiscal year that ended in Dec. 2023 is calculated as

	Days Payable (A: Dec. 2023 )
=	Average Accounts Payable					/	Cost of Goods Sold	*	Days in Period
=	( (Accounts Payable (A: Dec. 2022 )	+	Accounts Payable (A: Dec. 2023 ))	/	count )	/	Cost of Goods Sold (A: Dec. 2023 )	*	Days in Period
=	( (571.408	+	591.673)	/	2 )	/	601.736	*	365
=	581.5405					/	601.736	*	365
=	352.75

H. Lundbeck AS's Days Payable for the quarter that ended in Mar. 2024 is calculated as:

	Days Payable (Q: Mar. 2024 )
=	Average Accounts Payable					/	Cost of Goods Sold	*	Days in Period
=	( (Accounts Payable (Q: Dec. 2023 )	+	Accounts Payable (Q: Mar. 2024 ))	/	count )	/	Cost of Goods Sold (Q: Mar. 2024 )	*	Days in Period
=	( (591.673	+	561.672)	/	2 )	/	135.322	*	365 / 4
=	576.6725					/	135.322	*	365 / 4
=	388.86

H. Lundbeck AS Days Payable Related Terms

Thank you for viewing the detailed overview of H. Lundbeck AS's Days Payable provided by GuruFocus.com. Please click on the following links to see related term pages.

H. Lundbeck AS (FRA:LDBB) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » H. Lundbeck AS (FRA:LDBB) » Definitions » Days Payable

Comparable Companies

Traded in Other Exchanges

HLBBF:USA HLUBF:USA 0ABR:UK 0ND5:UK HLUN A:Denmark HLUN B:Denmark LDBA:Germany

Address

Ottiliavej 9, Valby, DNK, 2500

Website

https://www.lundbeck.com

Lundbeck is a Denmark-based pharmaceutical firm that focuses on the development and commercialization of central nervous system, or CNS, drugs including antidepressants, antipsychotics, and antiepileptic products. The company's portfolio includes Abilify Maintena and Rexulti for psychosis, Brintellix/Trintellix for depression, Northera for Parkinson's disease symptoms, Sabril and Onfi for seizures, and Vyepti for migraine prevention. Most of the company's sales are derived in North America, followed by Asia and Europe.

H. Lundbeck AS (FRA:LDBB) Headlines

No Headlines